Manus Neurodynamica

Prioritising Parkinson's Disease and other neurological conditions with earlier diagnosis and appropriate care.

[Manus Neurodynamica @Manusneuro]

⭐️Senior Leadership Spotlight⭐️

🕴️Albert Nicholl, our #Chair

💷Experienced Medtech Chair with vast commercial experience, having held CEO roles and worked at a senior level in many healthcare companies

🌟NED roles in companies to raise investment, build teams & commercialise

[Manus Neurodynamica @Manusneuro]

⭐️Senior Leadership Spotlight⭐️

👨‍💼Phil Pattison, our #CFO

📈With a rich finance & commercial background, he brings extensive skillset & expertise to the Group

👉Also a CFO of TotalLab Ltd, an industry-led life science image analysis software company

[Manus Neurodynamica @Manusneuro]

“The digital biomarkers obtained in a quick, simple way by the Neuromotor Pen give hugely valuable objective insights into movement abnormalities, and the device has the ability to improve the pathway for patients with these disorders and healthcare professionals.”

[Manus Neurodynamica @Manusneuro]

⭐️Senior Leadership Spotlight⭐️

Our #COO, Dr David Bramwell

👉Responsible for the technology delivery of the #NMP - its potential in impacting millions of lives

🎯Focus on driving continual improvement across all aspects of product delivery

[Manus Neurodynamica @Manusneuro]

David has extensive experience in innovative diagnostics, having founded a company focused on the discovery and validation of novel biosignatures.

[Manus Neurodynamica @Manusneuro]

Roberto has a passion for innovative Health-Tech solutions with a special interest in neurology, having previously set up a distribution network, and is responsible for driving sales of the NeuroMotor Pen™.

[Manus Neurodynamica @Manusneuro]

We were delighted last year to share the expansion of the Senior Management team and Board in the last year - with a new VP Sales, COO, CFO & Chairman.

Want to know more about them? Check our Senior Leadership Spotlights posts over the coming days🌟

https://t.co/CIE8o5vmer

[Manus Neurodynamica @Manusneuro]

⭐️Senior Leadership Spotlight⭐️

👨‍💼Roberto Marcucci, VP sales

🌟An experienced Senior Sales Manager with nearly 20 yrs of demonstrated successes in sales and ditribution management in SaaS & medical devices

🗒️Responsible for building the sales pipeline for #NeuroMotorPen

[Manus Neurodynamica @Manusneuro]

It was a privilege to be part of the 2023 #XmasLectures from the Royal Institution examining AI. Our CEO, Rutger Zietsma joined Professor Mike Wooldridge to demonstrate how The NeuroMotor Pen™ can aid the diagnoses of Parkinson's Disease.

📺 Watch the series on BBC iPlayer

#AI

[Manus Neurodynamica @Manusneuro]

📺 Don’t miss tonight’ final lecture 8pm on BBC Four & BBC iPlayer

#AI #ArtificialIntelligence

[Royal Institution (now on Bluesky) @Ri_Science]

The final instalment of our 2023 #XmasLectures, supported by CGI, is tonight 🙌

Join @wooldridgemike as he explores some of the risks of AI - which are real and which are imagined?

Find out tonight on BBC Four & iPlayer from 8pm.

[Manus Neurodynamica @Manusneuro]

✍️For more information about how the Pen works and can support diagnoses and monitor PD, visit our website: https://t.co/kzWa4xrCEh

#Parkinsonsdisease #NeuroMotorPen

[Manus Neurodynamica @Manusneuro]

✍️ It was a privilege to be part of last night’s #XmasLectures from the Royal Institution!

Our CEO, Rutger Zietsma joined Professor Mike Wooldridge to demonstrate how The NeuroMotor Pen™ can aid the diagnoses of Parkinson's Disease.

#Parkinsonsdisease #NeuroMotorPen

[Manus Neurodynamica @Manusneuro]

✍️The NeuroMotor Pen™ device with decision support algorithm, using biomarkers can assess with a high level of accuracy, whether that individual has Parkinson’s Disease.

#Parkinsonsdisease #NeuroMotorPen

[Royal Institution (now on Bluesky) @Ri_Science]

Hello to @ruskin147 and Rutger Zietsma from @Manusneuro, explaining the ways AI is being used to help diagnose Parkinson’s disease.

#XmasLectures

[Manus Neurodynamica @Manusneuro]

Don’t miss tonight’s #XmasLectures from @Ri_Science where @wooldridgemike will reveal the huge role AI plays in our daily lives, featuring some of the revolutionary innovations that AI has brought about in healthcare.👇

📺 8pm on BBC Four on & BBC iPlayer

#AI

[Royal Institution (now on Bluesky) @Ri_Science]

The second instalment of our 2023 #XmasLectures, supported by CGI, is tonight 🙌

Join @wooldridgemike as he explores the ways in which we already encounter AI in our daily lives.

📺 Watch on BBC Four & iPlayer from 8pm.

[Manus Neurodynamica @Manusneuro]

AI is transforming our everyday lives, to find out more check this year’s #XmasLectures from @Ri_Science where @wooldridgemike will reveal the truth about AI
👇

📺 8pm on BBC Four on 26, 27, 28 December & BBC iPlayer

#AI #ArtificialIntelligence

[Royal Institution (now on Bluesky) @Ri_Science]

AI is the most rapidly evolving area of science today

Join @wooldridgemike for the #XmasLectures, supported by CGI, revealing the truth about AI -  from its impact on daily life to showing how AI technology really works

📺8pm on BBC Four on 26, 27, 28 December & BBC iPlayer

[Manus Neurodynamica @Manusneuro]

We're delighted to have been shortlisted for 'Best Startup' at the @GalienFdn Prix Galien USA Awards 2023.

The #PrixGalien Awards acknowledge leading advances in life sciences, with the awards ceremony taking place in October in New York.

[The Galien Foundation @GalienFdn]

The Galien Foundation is delighted to announce the 2023 #PrixGalien USA Awards nominees for “Best Digital Health Solution," “Best Medical Technology,” "Incubators, Accelerators and Equity," and "Best Startup". Full list available here: https://t.co/ejl9kh4P2I

[Manus Neurodynamica @Manusneuro]

📰We're delighted to be featured in the article published today by @INVIVOnow, "Parkinson’s Disease: Ripe For A Rethink."

🔗Read the full article here: https://t.co/qvy7KFXFk9

#ParkinsonsDisease #NeuroMotorPen

[Manus Neurodynamica @Manusneuro]

The NeuroMotor Pen™ is a technological and scientific quantum leap forward in the early diagnosis of #Parkinsons and other adverse effects, such as post-immunotherapy.

It's a unique, patented, simple digital device that will revolutionise neurological healthcare as we know it.